Treatment of chronic mesenteric ischemia has evolved over the last two decades. Endovascular therapy is now the treatment of choice for patients with lesions amenable to such an approach. Open revascularization remains the standard of care but is frequently being reserved for lesions containing intraluminal thrombus or severe calcification. In most cases, celiac axis (CA) stenting is not needed since revascularization of the superior mesenteric artery (SMA) alone results in symptomatic resolution. This report describes a case of a patient with chronic mesenteric ischemia and diffuse gastric ulcers found to have a common origin of the SMA and CA that was treated endovascularly using a bifurcated stent technique.
Introduction
Chronic mesenteric ischemia (CMI) is a rare clinical entity most often caused by atherosclerotic ostial lesions in at least two of the three main visceral arteries. The most common presenting symptoms include abdominal pain, weight loss, "fear of food," diarrhea, nausea, and vomiting. 1 Over the last two decades, endovascular therapy has emerged as the preferred treatment modality for patients with short ostial lesions. Open repair remains the treatment of choice for long lesions with intraluminal thrombus or severe calcification. [2] [3] [4] [5] [6] In most cases, revascularization of a single vessel sufficiently provides symptomatic relief. However, it would appear logical that in patients presenting with diffuse ischemic gastric ulcers and poor collateral network, celiac axis (CA) revascularization may be required. Furthermore, multiple-vessel revascularization has been reported to increase graft patency and survival in patients with 3-vessel disease. 7 Presented here is a case of a 73-year-old female with CMI found to have a heavily calcified and subtotally occluded common origin of the CA and superior mesenteric artery (SMA) with disease extending into both vessels that was treated percutaneously using orbital atherectomy (OA) and bifurcated stent technique. The patient consented for the publication of this report.
Case Report
A 73-year-old female presented to her primary care physician with complaints of postprandial abdominal pain, diarrhea, nausea, vomiting, and 40-pound weight loss in 3 months. Her cardiovascular risk factors included hypertension, hyperlipidemia, myocardial infarction, ongoing tobacco abuse, and chronic obstructive pulmonary disease (COPD) on 3 L home oxygen. A right upper quadrant ultrasound ruled out cholelithiasis. An esophagogastroduodenoscopy (EGD) showed diffuse gastric ulcers negative for Helicobacter pylori or malignancy. She was placed on proton pump inhibitors (PPIs) with no relief of symptoms. A repeat EGD 6 weeks later revealed worsening gastric ulcers. A colonoscopy revealed sloughing of the mucosa. A computed tomography angiography (CTA) of the abdomen/pelvis revealed heavily calcified and subtotally occluded common origin of the CA and SMA (Figure 1 ). Peak systolic and end-diastolic velocities of the common CA/SMA trunk were 578 cm/s and 72 cm/s, respectively, on a mesenteric ultrasound. An echocardiogram obtained at our institution showed no wall motion abnormality with an ejection fraction of 45%. A poor candidate for general anesthesia, she was offered endovascular revascularization under local anesthesia.
The procedure was performed percutaneously via a left transbrachial approach. Systemic heparinization was achieved prior to instrumentation of the distal aortic arch. A 7F Raabe sheath (Cook Medical, Bloomington, Indiana) was advanced into the abdominal aorta over a previously placed Rosen wire and a 7F MPA guide catheter (Cook Medical) used to engage the stump of the CA/SMA common origin. The lesion was traversed with Glidewire (Terumo, Somerset, New Jersey) and a 4F catheter. Angiogram confirmed patency of distal SMA branches ( Figure 2A ). Attempts to advance a 3-mm angioplasty balloon through the lesion were unsuccessful. A 0.014 Viper guidewire (Cardiovascular System, Inc, St Paul, Minnesota) was advanced into the SMA and a 2-mm Diamondback 360 Orbital Atherectomy System (Cardiovascular System, Inc) used to debulk the calcified lesion at a rotational speed of 120 rpm. Following multiple passes, angiography revealed a large enough lumen to accommodate a stent. A 6-mm, 0.014 Spider Rx filter wire (Covidien, Mansfield, Massachusetts) was delivered through a Quick-Cross catheter and deployed in the SMA. A 0.018 buddy wire was advanced into the SMA and a 7 mm Â 22 mm Atrium iCAST stent graft (Marquet, Germany), delivered over both wires, was deployed into the common CA/SMA origin making certain not to "jail" the origin of the CA ( Figure 2B ). Since the disease extended into the SMA and CA, a 7 mm Â 40 mm Protégé stent (Covidien) was deployed into the SMA extending past the origin of the CA ( Figure 2C ).
The cell of the Protégé stent was cannulated with a 0.014 wire that was advanced into the hepatic artery ( Figure 2D) . A gradient of 32 mm Hg was noted across the lesion. Attempt to advance a 3-mm balloon across the lesion was unsuccessful. Instead, the origin of the CA was serially dilated with a 2-mm and 3-mm angioplasty balloon prior to placing a 5 mm Â 2 cm Express LD stent (Boston Scientific, Marlborough, Massachusetts), thus creating a bifurcated stent. Patency of CA, SMA, and distal branches was confirmed by angiography ( Figure 2E ). Total fluoroscopy time and dose were 43 minutes and 587 mGy, respectively.
A CTA obtained prior to discharge demonstrated patent CA, SMA, and common trunk ( Figure 3A) . A repeat EGD 4 weeks later revealed complete healing of her gastric ulcers. At 3-month follow-up, she reported complete resolution of all her symptoms and gained 19 pounds. A CTA obtained 32 months postintervention confirmed continued patency of all stents ( Figure 3B ).
Discussion
Initially considered a bridge to open repair, visceral artery angioplasty and stenting in patients with CMI has emerged as the preferred treatment modality for lesions amenable to such interventions. 1, 4, 5, 8, 9 Anatomical limitations to this approach include heavily calcified/long-segment lesions, tandem lesions, and those containing thrombus or debris. 9, 10 Revascularization of a single visceral artery-usually the SMA-sufficiently relieves symptoms of CMI. However, higher patency and increased survival have been reported in patients with 3-vessel disease treated with complete revascularization. 7 The case discussed here is unique since the patient presented with gastric, small, and large intestine ischemia as demonstrated by the findings on EGD and colonoscopy. Furthermore, the common CA/SMA trunk disease extended past both vessels takeoffs.
A valid argument can be made to "wait and see" if stenting of the SMA alone would have resulted in healing of gastric ulcers. This thought was entertained, but the extent of gastric ulcerations; the high gradient (32 mm Hg) across the lesion; and the fact that the patient was frail, lived 130 miles away from our center, and had poor support system led us to proceed with treatment of the lesion. The patient had a large marginal artery of Drummond, suggesting that revascularization of the SMA would likely be sufficient in reversing ischemic colitis documented on colonoscopy. The optimal treatment for this patient was a supraceliac aorta to CA and SMA bypass. The patient, however, was a poor candidate for general anesthesia given her COPD and frail state.
While feasible, stenting of heavily calcified ostial and tandem mesenteric lesions has reported long-term failure rates as high as 60%. 3 We previously reported on the use of OA to debulk heavily calcified mesenteric lesions prior to angioplasty and stenting. 6 The goal here is to reduce calcium burden since this is one of the demonstrated causes of restenosis following mesenteric stenting. 3, 6 The safety and efficacy of this technique in debulking calcified lesions has also been demonstrated in the lower extremity and coronary arteries. 11, 12 The debate over covered stent (CS) versus bare metal stent (BMS) for treatment of mesenteric lesions remains unsettled. Higher patency has been reported in aortoiliac occlusive lesions treated with CS compared to those treated with BMS. 13 In our practice, a CS is favored for treatment of ostial mesenteric lesions. If a CS cannot be used, our preference is to use a balloon-expandable BMS for calcified lesions because of superior radial force and precise deployment. In this case, an opencell, self-expending BMS was placed in the SMA past the origin of the CA to allow for cannulation of the cell of this stent and placement of a balloon-expendable BMS to treat the CA lesion.
Conclusion
Along with malignancy, chronic gastric ischemia should be considered in patients with gastric ulcers recalcitrant to PPIs. In most patients with CMI, stenting of a single vessel usually results in resolution of symptoms. In rare cases, however, CA revascularization may be needed. Bifurcated stent technique can be a useful approach in poor surgical candidates with unusual anatomy requiring revascularization of both the CA and SMA. A. Via a left transbrachial approach, a 7F MPA guide catheter and a 4F catheter are used to engage the stump of the heavily calcified celiac artery (CA)/superior mesenteric artery (SMA) common origin. The lesion is crossed with a straight tip, 0.035-in Glidewire. Orbital atherectomy was used to debulk the lesion prior to placing a stent graft. B, Improvement in flow across the lesion postatherectomy. A 7 mm Â 22 mm atrium iCAST stent graft is positioned and ready to be deployed. C, A 7 Â 22 mm atrium stent (common origin) and the self-expanding stent (SMA) now in place. Note the presence of calcific disease in the celiac artery. Since the patient had extensive gastric ulcers recalcitrant to proton pump inhibitors (PPIs), we felt compelled to treat this lesion. D and E, The cell of the self-expandable stent is now catheterized and stented with a balloon-expendable stent with excellent flow into the celiac artery (CA) and its branches.
